|
Said R. Beydoun, MD
Said R. Beydoun, MD, FAAN, Professor and Division Chief, Neuromuscular Medicine, at the Department of Neurology at Keck Medicine of USC, University of Southern California. He is Program Director of the Clinical Neurophysiology Fellowship. As a principal investigator, Dr. Beydoun has participated in multiple research clinical trials. His clinical and research areas of expertise in the field of Neuromuscular Medicine include: ALS, Myasthenia Gravis, Peripheral Neuropathy including CIDP, Multifocal Motor Neuropathy, and TTR Amyloid Neuropathy. He has been published in several scientific journals on topics related to neuromuscular diseases. He is editor-in-Chief of US Neurology. He is an elected fellow of the American Academy of Neurology and a fellow of the American Association of Neuromuscular and Electrodiagnostic Medicine. He is a member of the medical/scientific advisory board of the Myasthenia Gravis Foundation of America. He is medical director of the Certified ALS Treatment Center of Excellence at Keck USC. He holds board certification by the American Board of Psychiatry and Neurology in Neurology, Clinical Neurophysiology, Neuromuscular Medicine, and Pain Medicine.
|
Session:
Updates on Multifocal Motor Neuropathy Course Description: This course will describe clinical presentations and electrophysiologic findings in MMN & discuss early, accurate diagnosis, and its impact on treatment and prognosis. Target Audience: This activity is intended for general neurologists, neuromuscular specialists, neurology nurse practitioners and physician assistants. Learning Objectives: 1. Describe the clinical presentation and electrophysiologic findings in MMN 2. Identify other neuromuscular disorders, which can mimic MMN 3. Discuss Treatment Options in MMN 4. Recognize the importance of early and accurate diagnosis, for treatment and prognosis implication |
To receive a Continuing Medical Education certificate, attend the presentation, complete the post-test, and the post-presentation evaluation.
